ArticleG3 (Bethesda, Md.)2026
SIN-3 coregulator maintains adaptive capacity to different diets in Caenorhabditis elegans through vitamin B12.
Article in G3 (Bethesda, Md.), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
Abstract
Diet has profound effects on metabolism and health, requiring animals to adapt their physiology to varying food sources. Here we show that the conserved SIN3 transcriptional coregulator is required in Caenorhabditis elegans for animals to adapt to different bacterial diets. Shifting sin-3 mutant animals from the commonly used E. coli OP50 strain to the E. coli HT115 strain used for RNAi knockdown experiments has a dramatic impact on survival, leading to the lethality of mutant animals at the young adult stage. A major difference between OP50 and HT115 is vitamin B12 content, which is lower in OP50 than HT115. Feeding sin-3 mutant animals on OP50 bacteria supplemented with vitamin B12 reproduced the lethality observed on HT115. Vitamin B12 functions in 2 metabolic pathways: the canonical propionate breakdown pathway and the methionine/S-adenosylmethionine (met/SAM) cycle. Loss of metr-1, encoding the methionine synthase enzyme that requires vitamin B12 as a cofactor in the met/SAM cycle repressed lethality on HT115. Conversely, complementation with metabolites of the met/SAM cycle enhanced lethality on OP50. These results show that SIN-3 is required for animals to adapt to dietary changes through B12-dependent metabolic pathways.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.